FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Geoffrey Dusheiko

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Concepts & Ideas

Treatment Outcome

Procedures

Drug Therapy, Combination

Co-author Network

Publications

TOP 3
Richard S Tedder; Mark Thursz; Roger Williams; Terry Wong; Mark Wright; Michael Anderson; Jangu Banatvala; Margaret Bassendine; Andrew Bathgate; George Bird; Shilpa Chokshi; Jane Collier; John F Dillon; Geoffrey Dusheiko; Lori Fries; Hyder Hussaini; Samreen Ijaz; Michael Jacobs; Anne M Johnson; Peter R Mills; Sulleman Moreea; David Mutimer; Nikolai Naoumov; Alison J Rodger; Gillian Rosenberg; William Rosenberg; Stephen D Ryder
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.
Geoffrey Dusheiko
Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
Geoffrey Dusheiko; Heiner Wedemeyer
New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Geoffrey Dusheiko (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard S Tedder; Mark Thursz; Roger Williams; Terry Wong; Mark Wright; Michael Anderson; Jangu Banatvala; Margaret Bassendine; Andrew Bathgate; George Bird; Shilpa Chokshi; Jane Collier; John F Dillon; Geoffrey Dusheiko; Lori Fries; Hyder Hussaini; Samreen Ijaz; Michael Jacobs; Anne M Johnson; Peter R Mills; Sulleman Moreea; David Mutimer; Nikolai Naoumov; Alison J Rodger; Gillian Rosenberg; William Rosenberg; Stephen D Ryder
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(7):951-60.
2013: Geoffrey Dusheiko
Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
Liver international : official journal of the International Association for the Study of the Liver 2013;33 Suppl 1():137-50.
2012: Geoffrey Dusheiko; Heiner Wedemeyer
New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye.
Gut 2012;61(12):1647-52.
2012: Abhishek Das; Geoffrey Dusheiko; Gidon Ellis; Upkar Gill; Patrick T F Kennedy; Pooja Khanna; Pietro Lampertico; Agnel Ross Lopes; Paul Blair; Maurizia Brunetto; Antony Chen; Claudia Mauri; Celeste Pallant; Dimitra Peppa; Mala K Maini
IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(8):3925-35.
2012: Geoffrey Dusheiko
Interruption of mother-to-infant transmission of hepatitis B: time to include selective antiviral prophylaxis?
Lancet 2012;379(9830):2019-21.
2012: Patrice Cacoub; Nicolas Dupin; Geoffrey Dusheiko; Christophe Hézode; Jann Lübbe; Odile Picard; Ramon Pujol; Marc Bourlière; Peter Buggisch; Siegfried Segaert; Bing Thio; Jean-Claude Roujeau
Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals.
Journal of hepatology 2012;56(2):455-63.
2012: Gaia Nebbia; Dimitra Peppa; William Rosenberg; Anna Schurich; Harsimran D Singh; Yang Cheng; Joanne ChinAleong; Geoffrey Dusheiko; Richard Gilson; Patrick Kennedy; Pooja Khanna; Mala K Maini
Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.
PloS one 2012;7(10):e47648.
2011: Andrew J Muir; Jean-Michel Pawlotsky; F Fred Poordad; Henk W Reesink; Mitchell L Shiffman; Stefan Zeuzem; Thomas Berg; Geoffrey Dusheiko; Peter Ferenci; Shelley George; E Jenny Heathcote; Robert S Kauffman; Emily C Martin; John G McHutchison; Nathalie Adda
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response.
Hepatology (Baltimore, Md.) 2011;54(5):1538-46.
2011: Ira M Jacobson; Robert S Kauffman; Tara L Kieffer; Patrick Marcellin; John G McHutchison; Andrew J Muir; K Rajender Reddy; Mario Rizzetto; Abdul J Sankoh; Daniel Shouval; Ricard Sola; Ruben A Terg; Eric M Yoshida; Stefan Zeuzem; Nathalie Adda; Leif Bengtsson; Natalie H Bzowej; Adrian M Di Bisceglie; Geoffrey Dusheiko; Peter Ferenci; Robert Flisiak; Jacob George; Shelley George
Telaprevir for previously untreated chronic hepatitis C virus infection.
The New England journal of medicine 2011;364(25):2405-16.
2011: Anna Schurich; Pooja Khanna; Agnel Ross Lopes; Ki Jun Han; Dimitra Peppa; Lorenzo Micco; Gaia Nebbia; Patrick T F Kennedy; Anna Maria Geretti; Geoffrey Dusheiko; Mala K Maini
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection.
Hepatology (Baltimore, Md.) 2011;53(5):1494-503.
2011: Tabinda Burney; Geoffrey Dusheiko
Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients.
Expert review of anti-infective therapy 2011;9(2):151-60.
2011: Michael Manns; Patrick Marcellin; Paul Meyvisch; Christophe Moreno; Monika Peeters; Henk Reesink; Vanitha Sekar; Kenneth Simmen; Thomas Berg; Geoffrey Dusheiko; Robert Flisiak; Oliver Lenz; Rene Verloes
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial.
Antiviral therapy 2011;16(7):1021-33.
2010: Julie Parkes; Paul Roderick; Scott Harris; Christopher Day; David Mutimer; Jane Collier; Martin Lombard; Graeme Alexander; John Ramage; Geoffrey Dusheiko; Mark Wheatley; Carol Gough; Alastair Burt; William Rosenberg
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.
Gut 2010;59(9):1245-51.
2010: Seán J Costelloe; Nancy Wassef; Josephine Schulz; Tina Vaghijiani; Catherine Morris; Stephen Whiting; Michael Thomas; Geoffrey Dusheiko; Michael Jacobs; Mark P J Vanderpump
Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapy.
Clinical endocrinology 2010;73(2):249-56.
2010: Nabil Antaki; Antonio Craxi; Sanaa M Kamal; Rami Moucari; Schalk Van der Merwe; Samir Haffar; Adrian Gadano; Nizar Zein; Ching Lung Lai; Jean-Michel Pawlotsky; E Jenny Heathcote; Geoffrey Dusheiko; Patrick Marcellin
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report.
Liver international : official journal of the International Association for the Study of the Liver 2010;30(3):342-55.
2010: Dimitra Peppa; Lorenzo Micco; Alia Javaid; Patrick T F Kennedy; Anna Schurich; Claire Dunn; Celeste Pallant; Gidon Ellis; Pooja Khanna; Geoffrey Dusheiko; Richard J Gilson; Mala K Maini
Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.
PLoS pathogens 2010;6(12):e1001227.
2009: Geoffrey Dusheiko
Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C.
Clinics in liver disease 2009;13(3):487-501.
2009: Christophe Hézode; Nicole Forestier; Geoffrey Dusheiko; Peter Ferenci; Stanislas Pol; Tobias Goeser; Jean-Pierre Bronowicki; Marc Bourlière; SHAHIN GHARAKHANIAN; Leif Bengtsson; Lindsay McNair; Shelley George; Tara Kieffer; Ann Kwong; Robert S Kauffman; John Alam; Jean-Michel Pawlotsky; Stefan Zeuzem
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
The New England journal of medicine 2009;360(18):1839-50.
2008: Mark Danta; N Semmo; P Fabris; D Brown; O G Pybus; C A Sabin; S Bhagani; V C Emery; Geoffrey Dusheiko; P Klenerman
Impact of HIV on host-virus interactions during early hepatitis C virus infection.
The Journal of infectious diseases 2008;197(11):1558-66.
2008: Patrick T F Kennedy; Natalie Phillips; Jaya Chandrasekhar; Ruth Jacobs; Michael Jacobs; Geoffrey Dusheiko
Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotyping.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(5):699-704.
2008: George V Papatheodoridis; Spilios Manolakopoulos; Geoffrey Dusheiko; Athanasios J Archimandritis
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.
The Lancet infectious diseases 2008;8(3):167-78.
2008: Jean-Michel Pawlotsky; Geoffrey Dusheiko; Angelos Hatzakis; Daryl Lau; George Lau; TSANYANG LIANG; Stephen Locarnini; Paul Martin; Douglas D Richman; Fabien Zoulim
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.
Gastroenterology 2008;134(2):405-15.
2008: Geoffrey Dusheiko; David Nelson; K Rajender Reddy
Ribavirin considerations in treatment optimization.
Antiviral therapy 2008;13 Suppl 1():23-30.
2008: Geoffrey Dusheiko; N Antonakopoulos
Current treatment of hepatitis B.
Gut 2008;57(1):105-24.
2007: John G McHutchison; Geoffrey Dusheiko; Mitchell L Shiffman; Maribel Rodriguez-Torres; Samuel Sigal; Marc Bourliere; Thomas Berg; Stuart Gordon; Fiona M Campbell; Dickens Theodore; Nicole Blackman; Julian Jenkins; Nezam H Afdhal
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
The New England journal of medicine 2007;357(22):2227-36.
2007: Mark Danta; David Brown; Sanjay Bhagani; Oliver G Pybus; Caroline A Sabin; Mark Nelson; Martin Fisher; Anne M Johnson; Geoffrey Dusheiko
Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.
AIDS (London, England) 2007;21(8):983-91.
2007: Geoffrey Dusheiko; Mark Danta
Telbivudine for the treatment of chronic hepatitis B.
Drugs of today (Barcelona, Spain : 1998) 2007;43(5):293-304.
2007: Stanca M Ciupe; Ruy M Ribeiro; Patrick W Nelson; Geoffrey Dusheiko; Alan S Perelson
The role of cells refractory to productive infection in acute hepatitis B viral dynamics.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(12):5050-5.
2006: Jim Gotto; George J M Webster; David Brown; J Jenkins; Geoffrey Dusheiko; Antonio Bertoletti
The impact of HBV-DNA fluctuations on virus-specific CD8+ T cells in HBeAg+ chronic hepatitis B patients treated with a steroid and lamivudine.
Journal of viral hepatitis 2006;13(6):415-25.
2006: Patrick T F Kennedy; Simona Urbani; Rebecca A Moses; Barbara Amadei; Paola Fisicaro; Jilly Lloyd; Mala K Maini; Geoffrey Dusheiko; Carlo Ferrari; Antonio Bertoletti
The influence of T cell cross-reactivity on HCV-peptide specific human T cell response.
Hepatology (Baltimore, Md.) 2006;43(3):602-11.
2006: Geoffrey Dusheiko
Candidates for therapy: HBV.
Journal of hepatology 2006;44(1 Suppl):S84-9.
2005: Kevin Moore; Geoffrey Dusheiko
Opiate abuse and viral replication in hepatitis C.
The American journal of pathology 2005;167(5):1189-91.
2005: Yoav Lurie; Régine Rouzier-Panis; George J M Webster; Geoffrey Dusheiko; Mark Laughlin; Mary L Jackson; Ran Oren
Optimal dosing frequency of pegylated interferon alfa-2b monotherapy for chronic hepatitis C virus infection.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(6):610-5.
2005: Mark Danta; Eleanor Barnes; Geoffrey Dusheiko
The surveillance and diagnosis of hepatocellular carcinoma.
European journal of gastroenterology & hepatology 2005;17(5):491-6.
2005: Geoffrey Dusheiko; Mark Danta
Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?
Nature clinical practice. Gastroenterology & hepatology 2005;2(3):130-1.
2005: Geoffrey Dusheiko; Antonio Bertoletti
Resistance to lamivudine therapy: is there more than meets the eye?
Gut 2005;54(1):9-10.
2004: Simon A Whalley; David Brown; George J M Webster; Ruth Jacobs; Stephanie Reignat; Antonio Bertoletti; Chong Gee Teo; Vincent Emery; Geoffrey Dusheiko
Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants.
Gastroenterology 2004;127(4):1131-8.
2004: James Gotto; Geoffrey Dusheiko
Hepatitis C and treatment with pegylated interferon and ribavirin.
The international journal of biochemistry & cell biology 2004;36(10):1874-7.
2004: Mark Danta; Geoffrey Dusheiko
Adefovir dipivoxil: review of a novel acyclic nucleoside analogue.
International journal of clinical practice 2004;58(9):877-86.
2004: Georg M Lauer; Eleanor Barnes; Michaela Lucas; Joerg Timm; Kei Ouchi; Arthur Y Kim; Cheryl L Day; Gregory Robbins; Deborah R Casson; Markus Reiser; Geoffrey Dusheiko; Todd M Allen; Raymond T Chung; Bruce D Walker; Paul Klenerman
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.
Gastroenterology 2004;127(3):924-36.
2004: Eleanor Barnes; Mariolina Salio; Vincenzo Cerundolo; Joanne Medlin; Shona Murphy; Geoffrey Dusheiko; Paul Klenerman
Impact of alpha interferon and ribavirin on the function of maturing dendritic cells.
Antimicrobial agents and chemotherapy 2004;48(9):3382-9.
2004: Eleanor Barnes; Scott M Ward; Victoria O Kasprowicz; Geoffrey Dusheiko; Paul Klenerman; Michaela Lucas
Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells.
European journal of immunology 2004;34(6):1570-7.
2004: George J M Webster; Stephanie Reignat; David Brown; Graham S Ogg; Louise Jones; Suranjith L Seneviratne; Roger Williams; Geoffrey Dusheiko; Antonio Bertoletti
Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy.
Journal of virology 2004;78(11):5707-19.
2004: Paolo Fabris; Dave Brown; Giulia Tositti; Loredana Bozzola; maria teresa giordani; Pierantonio Bevilacqua; Fausto De Lalla; George J M Webster; Geoffrey Dusheiko
Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;29(3):160-6.
2003: Ali Judd; John Parry; Matthew Hickman; Tamara McDonald; Laura Jordan; Kim Lewis; Marcela Contreras; Geoffrey Dusheiko; Graham Foster; Noël Gill; Katie Kemp; Janice Main; Iain M Murray-Lyon; Mark Nelson
Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots.
Journal of medical virology 2003;71(1):49-55.
2003: Fabio Malacarne; George J M Webster; Stephanie Reignat; Jim Gotto; Shahriar Behboudi; Andrew Kenneth Burroughs; Geoffrey Dusheiko; Roger Williams; Antonio Bertoletti
Tracking the source of the hepatitis B virus-specific CD8 T cells during lamivudine treatment.
The Journal of infectious diseases 2003;187(4):679-82.
2003: Michaela Lucas; Stephan D Gadola; Ute Meier; Neil T Young; Gillian Harcourt; Anastasios Karadimitris; Nikki Coumi; Dave Brown; Geoffrey Dusheiko; Vincenzo Cerundolo; Paul Klenerman
Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection.
Journal of virology 2003;77(3):2251-7.
2003: Maria Kantzanou; Michaela Lucas; Eleanor Barnes; Harvki Komatsu; Geoffrey Dusheiko; Scott Ward; Gillian Harcourt; Paul Klenerman
Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers.
Immunology letters 2003;85(2):165-71.
2003: Geoffrey Dusheiko
Adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B: a review of the major clinical studies.
Journal of hepatology 2003;39 Suppl 1():S116-23.
2002: Geoffrey Dusheiko
HCV infection should be managed in specialist centres.
Gut 2002;51(5):625-6.
2002: Caroline A Sabin; Vince Emery; Helen L Devereux; Anja Griffioen; Jeremy Bishop; Geoffrey Dusheiko; Thynn Thynn Yee; Esteban Herrero-Martinez; Christine A Lee
Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders.
Journal of medical virology 2002;68(1):68-75.
2002: Eleanor Barnes; Gillian Harcourt; Dave Brown; Michaela Lucas; Rodney Phillips; Geoffrey Dusheiko; Paul Klenerman
The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2002;36(3):743-54.
2002: Stephanie Reignat; George J M Webster; David Brown; Graham S Ogg; Abigail King; Suranjith L Seneviratne; Geoffrey Dusheiko; Roger Williams; Mala K Maini; Antonio Bertoletti
Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection.
The Journal of experimental medicine 2002;195(9):1089-101.
2001: George V Papatheodoridis; S Davies; Amar P Dhillon; Rosângela Teixeira; John Goulis; Brian Davidson; Keith Rolles; Geoffrey Dusheiko; Andrew Kenneth Burroughs
The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis.
Transplantation 2001;72(3):412-8.
2001: Simon A Whalley; J M Murray; David Brown; George J M Webster; V C Emery; Geoffrey Dusheiko; A S Perelson
Kinetics of acute hepatitis B virus infection in humans.
The Journal of experimental medicine 2001;193(7):847-54.
2001: K Brechtbuehl; Simon A Whalley; Geoffrey Dusheiko; N A Saunders
A rapid real-time quantitative polymerase chain reaction for hepatitis B virus.
Journal of virological methods 2001;93(1-2):105-13.
2001: Simon A Whalley; David Brown; Chong Gee Teo; Geoffrey Dusheiko; N A Saunders
Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler.
Journal of clinical microbiology 2001;39(4):1456-9.
2001: Anastasios Karadimitris; Stephan D Gadola; M Altamirano; D Brown; A Woolfson; Paul Klenerman; J L Chen; Y Koezuka; Irene A G Roberts; David A Price; Geoffrey Dusheiko; César Milstein; Alan Fersht; Lucio Luzzatto; Vincenzo Cerundolo
Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3294-8.
2000: Thynn Thynn Yee; Anja Griffioen; Caroline A Sabin; Geoffrey Dusheiko; Christine A Lee
The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985.
Gut 2000;47(6):845-51.
2000: George J M Webster; Stephanie Reignat; Mala K Maini; Simon A Whalley; Graham S Ogg; A King; David Brown; Peter L Amlot; Roger Williams; Diego Vergani; Geoffrey Dusheiko; Antonio Bertoletti
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.
Hepatology (Baltimore, Md.) 2000;32(5):1117-24.
2000: D Mutimer; Geoffrey Dusheiko; C Barrett; LF Grellier; M Ahmed; G Anschuetz; Andrew Kenneth Burroughs; S Hubscher; A P Dhillon; Keith Rolles; Elwyn Elias
Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up.
Transplantation 2000;70(5):809-15.
2000: Franziska Lechner; J Sullivan; Hans M L Spiegel; D F Nixon; B Ferrari; A Davis; B Borkowsky; H Pollack; Eleanor Barnes; Geoffrey Dusheiko; Paul Klenerman
Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2000;355(1400):1085-92.
2000: Geoffrey Dusheiko; Eleanor Barnes; G Webster; Simon Whalley
The science, economics, and effectiveness of combination therapy for hepatitis C.
Gut 2000;47(2):159-61.
2000: George J M Webster; Rachel L Hallett; Simon A Whalley; M Meltzer; K Balogun; David Brown; C P Farrington; S Sharma; G Hamilton; S C Farrow; Mary E Ramsay; Chong Gee Teo; Geoffrey Dusheiko
Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy.
Lancet 2000;356(9227):379-84.
2000: SI Khakoo; Roger Ling; I Scott; AI Dodi; Tim J Harrison; Geoffrey Dusheiko; J Alejandro Madrigal
Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.
Gut 2000;47(1):137-43.
2000: G Webster; Eleanor Barnes; D Brown; Geoffrey Dusheiko
HCV genotypes--role in pathogenesis of disease and response to therapy.
Baillière's best practice & research. Clinical gastroenterology 2000;14(2):229-40.
1999: Eleanor Barnes; G Webster; Simon Whalley; Geoffrey Dusheiko
Predictors of a favorable response to alpha interferon therapy for hepatitis C.
Clinics in liver disease 1999;3(4):775-91.
1999: Mahomed A Sathar; PN Soni; R Pegoraro; Peter Simmonds; DB Smith; A P Dhillon; Geoffrey Dusheiko
A new variant of GB virus C/hepatitis G virus (GBV-C/HGV) from South Africa.
Virus research 1999;64(2):151-60.
1999: R Pawson; S Rajan; G Hazlehurst; Geoffrey Dusheiko; R Miller; P Hewitt; A Mehta
Hepatitis C lookback programme: a single hospital experience.
Transfusion medicine (Oxford, England) 1999;9(3):189-93.
1999: George V Papatheodoridis; S G Barton; D Andrew; GS Clewley; S Davies; Amar P Dhillon; Geoffrey Dusheiko; B Davidson; Keith Rolles; Andrew Kenneth Burroughs
Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens.
Gut 1999;45(3):427-34.
1999: George V Papatheodoridis; David Patch; Geoffrey Dusheiko; Andrew Kenneth Burroughs
The outcome of hepatitis C virus infection after liver transplantation--is it influenced by the type of immunosuppression?
Journal of hepatology 1999;30(4):731-8.
1999: Geoffrey Dusheiko
A pill a day, or two, for hepatitis B?
Lancet 1999;353(9158):1032-3.
1999: Eleanor Barnes; G Webster; R Jacobs; Geoffrey Dusheiko
Long-term efficacy of treatment of chronic hepatitis C with alpha interferon or alpha interferon and ribavirin.
Journal of hepatology 1999;31 Suppl 1():244-9.
1999: Geoffrey Dusheiko
Lamivudine therapy for hepatitis B infection.
Scandinavian journal of gastroenterology. Supplement 1999;230():76-81.
1998: Caroline A Sabin; Helen L Devereux; Z Kinson; Anja Griffioen; D Brown; Geoffrey Dusheiko; Christine A Lee
Effect of coinfection with hepatitis G virus on HIV disease progression in hemophilic men.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(5):546-8.
1998: SI Khakoo; P Glue; LF Grellier; B Wells; A Bell; C Dash; I Murray-Lyon; D Lypnyj; B Flannery; K Walters; Geoffrey Dusheiko
Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.
British journal of clinical pharmacology 1998;46(6):563-70.
1998: Helen L Devereux; Caroline A Sabin; Z Kinson; D Brown; Anja Griffioen; Geoffrey Dusheiko; Christine A Lee
Influence of HIV-1 infection on GBV-C infection in multiply infected haemophilic patients.
Journal of medical virology 1998;56(4):316-20.
1998: PN Soni; D Brown; R Saffie; K Savage; D Moore; Gregory Gregoriadis; Geoffrey Dusheiko
Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
Hepatology (Baltimore, Md.) 1998;28(5):1402-10.
1998: Geoffrey Dusheiko
The natural course of chronic hepatitis C: implications for clinical practice.
Journal of viral hepatitis 1998;5 Suppl 1():9-12.
1998: A Morris; A David B Webster; D Brown; Tim J Harrison; Geoffrey Dusheiko
GB virus C infection in patients with primary antibody deficiency.
The Journal of infectious diseases 1998;177(6):1719-22.
1998: S Manolakopoulos; A Morris; S Davies; D Brown; S Hajat; Geoffrey Dusheiko
Influence of GB virus C viraemia on the clinical, virological and histological features of early hepatitis C-related hepatic disease.
Journal of hepatology 1998;28(2):173-8.
1997: Geoffrey Dusheiko
Side effects of alpha interferon in chronic hepatitis C.
Hepatology (Baltimore, Md.) 1997;26(3 Suppl 1):112S-121S.
1997: LF Grellier; Geoffrey Dusheiko
The role of hepatitis C virus in alcoholic liver disease.
Alcohol and alcoholism (Oxford, Oxfordshire) 1997;32(2):103-11.
1997: SI Khakoo; PN Soni; K Savage; D Brown; A P Dhillon; Leonard W Poulter; Geoffrey Dusheiko
Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity.
The American journal of pathology 1997;150(3):963-70.
1997: Helen L Devereux; D Brown; Geoffrey Dusheiko; Vincent C Emery; Christine A Lee
Long-term evolution of the 5'UTR and a region of NS4 containing a CTL epitope of hepatitis C virus in two haemophilic patients.
The Journal of general virology 1997;78 ( Pt 3)():583-90.
1997: LF Grellier; D Brown; J Power; Geoffrey Dusheiko
Absence of anti-envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977.
Journal of viral hepatitis 1997;4(6):379-81.
1997: LF Grellier; Geoffrey Dusheiko
Hepatitis B virus and liver transplantation: concepts in antiviral prophylaxis.
Journal of viral hepatitis 1997;4 Suppl 1():111-6.
1996: LF Grellier; David Mutimer; M Ahmed; D Brown; Andrew Kenneth Burroughs; Keith Rolles; P McMaster; P Beranek; F Kennedy; H Kibbler; P McPhillips; Elwyn Elias; Geoffrey Dusheiko
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis.
Lancet 1996;348(9036):1212-5.
1996: Geoffrey Dusheiko; J Main; Howard Thomas; Olle Reichard; C Lee; A Dhillon; S Rassam; A Fryden; H Reesink; M Bassendine; Gunnar Norkrans; T Cuypers; N Lelie; P Telfer; J Watson; C Weegink; P Sillikens; Ola Weiland
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.
Journal of hepatology 1996;25(5):591-8.
1996: S I Khakoo; P N Soni; D Brown; Geoffrey Dusheiko
A clinical evaluation of a new method for HBV DNA quantitation in patients with chronic hepatitis B.
Journal of medical virology 1996;50(2):112-6.
1996: S I Khakoo; LF Grellier; P N Soni; S Bhattacharya; Geoffrey Dusheiko
Etiology, screening, and treatment of hepatocellular carcinoma.
The Medical clinics of North America 1996;80(5):1121-45.
1996: Geoffrey Dusheiko
New treatments for chronic viral hepatitis B and C.
Baillière's clinical gastroenterology 1996;10(2):299-333.
1996: Peter Simmonds; J Mellor; A Craxi; J M Sanchez-Tapias; A Alberti; J Prieto; M Colombo; M G Rumi; O Lo Iacano; S Ampurdanes-Mingall; X Forns-Bernhardt; Liliana Chemello; M P Civeira; C Frost; Geoffrey Dusheiko
Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients.
Journal of hepatology 1996;24(5):517-24.
1996: Geoffrey Dusheiko; S Khakoo; P Soni; LF Grellier
A rational approach to the management of hepatitis C infection.
BMJ (Clinical research ed.) 1996;312(7027):357-64.
1996: A L Martinelli; D Brown; H B Braun; G Michel; Geoffrey Dusheiko
Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
Journal of hepatology 1996;24(1):21-6.
1996: Helen L Devereux; P Telfer; D Brown; A Morris; Geoffrey Dusheiko; Vincent C Emery; C Lee
Longitudinal genotype analysis and quantification of hepatitis C virus in haemophilic patients receiving interferon-alpha therapy.
Journal of viral hepatitis 1996;3(1):43-8.
1996: A David B Webster; D Brown; A Franz; Geoffrey Dusheiko
Prevalence of hepatitis C in patients with primary antibody deficiency.
Clinical and experimental immunology 1996;103(1):5-7.
1995: P T Telfer; Helen L Devereux; Kay Savage; F Scott; Amar P Dhillon; Geoffrey Dusheiko; Christine A Lee
Chronic hepatitis C virus infection in haemophilic patients: clinical significance of viral genotype.
Thrombosis and haemostasis 1995;74(5):1259-64.
1995: M S Smith; A David B Webster; Amar P Dhillon; Geoffrey Dusheiko; R Boulton; Kay Savage; Keith Rolles; Andrew Kenneth Burroughs
Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency.
Gastroenterology 1995;108(3):879-84.
1995: Helen L Devereux; P Telfer; Geoffrey Dusheiko; C Lee
Hepatitis C genotypes in haemophilic patients treated with alpha-interferon.
Journal of medical virology 1995;45(3):284-7.
1995: Kay Savage; Amar P Dhillon; H Schmilovitz-Weiss; M el-Batanony; D Brown; Geoffrey Dusheiko; Peter J Scheuer
Detection of HCV-RNA in paraffin-embedded liver biopsies from patients with autoimmune hepatitis.
Journal of hepatology 1995;22(1):27-34.
1995: Geoffrey Dusheiko
Treatment and prevention of chronic viral hepatitis.
Pharmacology & therapeutics 1995;65(1):47-73.
1994: M H el-Batanony; Kay Savage; R Jacobs; A O el-Refaie; Giuseppe Squadrito; D Brown; S M Saleh; A A Raouf; K M Amer; Geoffrey Dusheiko
Hepatitis C virus-polymerase chain reaction of routinely processed liver biopsies.
Journal of medical virology 1994;43(4):380-5.
1994: Geoffrey Dusheiko
Management of chronic hepatitis B and C.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1994;84(8 Pt 2):563-70.
1994: P Telfer; C Sabin; Helen L Devereux; F Scott; Geoffrey Dusheiko; C Lee
The progression of HCV-associated liver disease in a cohort of haemophilic patients.
British journal of haematology 1994;87(3):555-61.
1994: Geoffrey Dusheiko
Rolling review--the pathogenesis, diagnosis and management of viral hepatitis.
Alimentary pharmacology & therapeutics 1994;8(2):229-53.
1994: Geoffrey Dusheiko; P Simmonds
Sequence variability of hepatitis C virus and its clinical relevance.
Journal of viral hepatitis 1994;1(1):3-15.
1994: Geoffrey Dusheiko; H Schmilovitz-Weiss; D Brown; F McOmish; P L Yap; S Sherlock; N McIntyre; P Simmonds
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease.
Hepatology (Baltimore, Md.) 1994;19(1):13-8.
1994: J R Novell; Alan J Green; Andrew J W Hilson; Geoffrey Dusheiko; R Dick; K E Hobbs
Selective radionuclide localisation in primary liver tumours (pilot study).
HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 1994;7(3):185-99; discussion 200.
1993: Geoffrey Dusheiko; Arie J Zuckerman
Treatment of chronic viral hepatitis.
The Journal of antimicrobial chemotherapy 1993;32 Suppl A():107-20.
1993: Peter Simmonds; F McOmish; PL Yap; S W Chan; C K Lin; Geoffrey Dusheiko; A A Saeed; E C Holmes
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.
The Journal of general virology 1993;74 ( Pt 4)():661-8.
1993: S M Donohue; Beatrix Wonke; A Victor Hoffbrand; J Reittie; Kanagasabai Ganeshaguru; P J Scheuer; D Brown; Geoffrey Dusheiko
Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia major.
British journal of haematology 1993;83(3):491-7.
1993: I Merican; S Sherlock; N McIntyre; Geoffrey Dusheiko
Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection.
The Quarterly journal of medicine 1993;86(2):119-25.
1993: Beatrix Wonke; S M Donohue; A Victor Hoffbrand; P J Scheuer; D Brown; Geoffrey Dusheiko
Recombinant alpha 2B interferon (IFN) in the treatment of chronic hepatitis C disease in thalassaemia major (TM).
Bone marrow transplantation 1993;12 Suppl 1():24-5.
1993: H Schmilovitz-Weiss; M Levy; N Thompson; Geoffrey Dusheiko
Viral markers in the treatment of hepatitis B and C.
Gut 1993;34(2 Suppl):S26-35.
1992: D Brown; L Powell; A Morris; S Rassam; S Sherlock; N McIntyre; Arie J Zuckerman; Geoffrey Dusheiko
Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
Journal of medical virology 1992;38(3):167-71.
1992: Geoffrey Dusheiko
Viral hepatitis.
The Practitioner 1992;236(1519):970-4.
1992: K E Hobbs; Geoffrey Dusheiko
Management of hepatocellular carcinoma.
Journal of hepatology 1992;15(3):281-3.
1992: J Xu; D Brown; T Harrison; Y Lin; Geoffrey Dusheiko
Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha.
Hepatology (Baltimore, Md.) 1992;15(6):1002-6.
1992: C Lee; J Chrispeels; P Telfer; Geoffrey Dusheiko
Hepatitis C antibody profile in adults with haemophilia and their sexual partners.
British journal of haematology 1992;81(1):133-4.
1992: G Varagona; D Brown; A Haase; Geoffrey Dusheiko
Increased steady-state levels of alpha-fetoprotein mRNA in hepatocellular carcinoma: an analysis by in situ hybridization.
Liver 1992;12(2):62-8.
1992: T J Harrison; Geoffrey Dusheiko
Hepatitis B virus and hepatitis delta virus.
Molecular and cell biology of human diseases series 1992;1():203-32.
1991: V Fonseca; M Thomas; Geoffrey Dusheiko
Thyrotropin receptor antibodies following treatment with recombinant alpha-interferon in patients with hepatitis.
Acta endocrinologica 1991;125(5):491-3.
1991: Geoffrey Dusheiko
Treatment of viral hepatitis.
Arctic medical research 1991;50(4):179-83.
1991: J R Novell; Geoffrey Dusheiko; N I Markham; K Reddy; R Dick; K E Hobbs
Selective regional chemotherapy of unresectable hepatic tumours using lipiodol.
HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 1991;4(3):223-34; discussion 234-6.
1991: Geoffrey Dusheiko
Alpha-interferon treatment of chronic hepatitis B infection: predictors of responsiveness.
Journal of gastroenterology and hepatology 1991;6 Suppl 1():7-12.
1991: L Belli; Geoffrey Dusheiko; K Rolles; Andrew Kenneth Burroughs
Liver transplantation for chronic viral hepatitis.
The Italian journal of gastroenterology 1991;23(1):36-41.
1990: L A Ellis; D Brown; J D Conradie; A Paterson; R Sher; J Millo; E Theodossiadou; Geoffrey Dusheiko
Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum.
Journal of medical virology 1990;32(4):249-51.
1990: Beatrix Wonke; A Victor Hoffbrand; D Brown; Geoffrey Dusheiko
Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major.
Journal of clinical pathology 1990;43(8):638-40.
1990: Geoffrey Dusheiko
Hepatocellular carcinoma associated with chronic viral hepatitis. Aetiology, diagnosis and treatment.
British medical bulletin 1990;46(2):492-511.
1990: Geoffrey Dusheiko; G Varagona
Treatment of viral hepatitis.
Progress in clinical and biological research 1990;324():123-33.
1989: Geoffrey Dusheiko; J D Conradie; B A Brink; T Marimuthu; R Sher
Differences in the regional prevalence of chronic hepatitis B in southern Africa--implications for vaccination.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1989;75(10):473-8.
1989: Geoffrey Dusheiko
Review article: the management of hepatitis A, B, D and non-A non-B.
Alimentary pharmacology & therapeutics 1989;3(1):1-20.
1989: Geoffrey Dusheiko; B A Brink; J D Conradie; T Marimuthu; R Sher
Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey.
American journal of epidemiology 1989;129(1):138-45.